Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: Implications for diagnosis, monitoring and treatment

Simon Schneider; Anja Batrice; Christoph Rischpler; Matthias Eiber; Tareq Ibrahim; Stephan G. Nekolla

doi:10.1093/eurheartj/eht335

Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: Implications for diagnosis, monitoring and treatment

Simon Schneider, Anja Batrice, Christoph Rischpler, Matthias Eiber, Tareq Ibrahim, Stephan G. Nekolla

Technical University of Munich

Research output: Contribution to journal › Comment/debate

72 Scopus citations

Original language	English
Pages (from-to)	312
Number of pages	1
Journal	European Heart Journal
Volume	35
Issue number	5
DOIs	https://doi.org/10.1093/eurheartj/eht335
State	Published - 1 Feb 2014

Access to Document

10.1093/eurheartj/eht335

Cite this

@article{e5cdf63a14844c77b94a600c8852d873,

title = "Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: Implications for diagnosis, monitoring and treatment",

author = "Simon Schneider and Anja Batrice and Christoph Rischpler and Matthias Eiber and Tareq Ibrahim and Nekolla, {Stephan G.}",

note = "Funding Information: Conflict of interest: Ulf Landmesser has received speaker fees or research grants from Merck, Roche and Pfizer. Stephan Gielen has received research grants from Deutsche Forschungsgemeinschaft (DFG). Speaker fees from Astra Zeneca, Novartis, and Bayer Healthcare.",

year = "2014",

month = feb,

day = "1",

doi = "10.1093/eurheartj/eht335",

language = "English",

volume = "35",

pages = "312",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis

T2 - Implications for diagnosis, monitoring and treatment

AU - Schneider, Simon

AU - Batrice, Anja

AU - Rischpler, Christoph

AU - Eiber, Matthias

AU - Ibrahim, Tareq

AU - Nekolla, Stephan G.

N1 - Funding Information: Conflict of interest: Ulf Landmesser has received speaker fees or research grants from Merck, Roche and Pfizer. Stephan Gielen has received research grants from Deutsche Forschungsgemeinschaft (DFG). Speaker fees from Astra Zeneca, Novartis, and Bayer Healthcare.

PY - 2014/2/1

Y1 - 2014/2/1

UR - http://www.scopus.com/inward/record.url?scp=84893860743&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/eht335

DO - 10.1093/eurheartj/eht335

M3 - Comment/debate

C2 - 23975480

AN - SCOPUS:84893860743

SN - 0195-668X

VL - 35

SP - 312

JO - European Heart Journal

JF - European Heart Journal

IS - 5

ER -

Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: Implications for diagnosis, monitoring and treatment

Access to Document

Other files and links

Cite this